Cargando…

Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance

Cancer Susceptibility Candidate 9 (CASC9) is a novel gene generating long non-coding RNA (lncRNA) with oncogenic potential that was first identified in esophageal cancer. In this study, we have found that CASC9 was overexpressed in gastric cancer (GC) compared to normal gastric tissue. A higher expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Chao, Sun, Lin, Zhang, Jiale, Zhao, Bochao, Chen, Xiuxiu, Xu, Huimian, Huang, Baojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362493/ https://www.ncbi.nlm.nih.gov/pubmed/28146436 http://dx.doi.org/10.18632/oncotarget.14871

Ejemplares similares

Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2022)

Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer
por: Zhao, Bochao, et al.
Publicado: (2018)

Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy
por: Lu, Huiwen, et al.
Publicado: (2021)

Novel strategies to reverse chemoresistance in colorectal cancer
por: Ma, Shu‐Chang, et al.
Publicado: (2023)

SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells
por: LIU, YING, et al.
Publicado: (2014)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
por: Chen, Xun, et al.
Publicado: (2020)

A novel insight of sentinel lymph node concept based on 1-3 positive nodes in patients with pT1-2 gastric cancer
por: Huang, Baojun, et al.
Publicado: (2011)

Molecular mechanisms of chemoresistance in gastric cancer
por: Shi, Wen-Jia, et al.
Publicado: (2016)

Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy
por: Miao, You-Han, et al.
Publicado: (2021)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
por: Zhang, Qiumo, et al.
Publicado: (2020)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

Efficacy and safety of immune checkpoint inhibitors in gastric cancer: a network meta-analysis of well-designed randomized controlled trials
por: Pan, Siwei, et al.
Publicado: (2021)

Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer
por: Huang, Weifeng, et al.
Publicado: (2014)

Association of perioperative allogeneic blood transfusions and long-term outcomes following radical surgery for gastric and colorectal cancers: systematic review and meta-analysis of propensity-adjusted observational studies
por: Zhang, Weilan, et al.
Publicado: (2023)

Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer
por: Wang, Jinou, et al.
Publicado: (2019)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
por: Ruan, Xiaohong, et al.
Publicado: (2019)

Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database
por: Huang, Baojun, et al.
Publicado: (2013)

RNF114 Silencing Inhibits the Proliferation and Metastasis of Gastric Cancer
por: Feng, Zongfeng, et al.
Publicado: (2022)

Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9
por: Zhang, Sisen, et al.
Publicado: (2015)

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?
por: Xu, Jing-Li, et al.
Publicado: (2020)

EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
por: Gong, Wenjing, et al.
Publicado: (2021)

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
por: Pan, Yue, et al.
Publicado: (2017)

Silencing ELMO3 Inhibits the Growth, Invasion, and Metastasis of Gastric Cancer
por: Hu, Yan, et al.
Publicado: (2018)

HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells
por: Yu, Chen, et al.
Publicado: (2023)

Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment
por: Sharma, Uttam, et al.
Publicado: (2020)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021)

High glucose promotes gastric cancer chemoresistance in vivo and in vitro
por: ZHAO, WEI, et al.
Publicado: (2015)

Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer
por: Qian, Xiaoling, et al.
Publicado: (2017)

Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019)

CAF promotes chemoresistance through NRP2 in gastric cancer
por: Yang, Yanpeng, et al.
Publicado: (2021)

CD9: A possible clue into breast cancer chemoresistance
por: Pacienza, Natalia, et al.
Publicado: (2019)

Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells
por: Hu, Jin-Long, et al.
Publicado: (2017)

Silencing of ENO1 by shRNA Inhibits the Proliferation of Gastric Cancer Cells
por: Qiao, Hui, et al.
Publicado: (2018)

ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells
por: Xie, Rui, et al.
Publicado: (2019)

SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop
por: An, Yifei, et al.
Publicado: (2020)

Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma
por: Zeng, Yong-Lian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_62u4h564aavr12o0elqcvk38dc